Leveraging Genedata Screener for Biophysical Developability Assessment in Discovery Biologics Screening

Successful biotherapeutic development requires optimizing multiple properties (such as thermal stability, aggregation risk, and expression efficiency) measured across diverse assay technologies. Integrating these data for candidate selection can be challenging, especially in early developability studies where assays are run at higher throughput.  

This webinar will explore the use of Genedata Screener in evaluating biophysical developability data, specifically focusing on dynamic light scattering (DLS) and differential scanning fluorimetry (DSF) (in particular, its label-free version, nanoDSF).  

Learn how these methods are incorporated into early screening workflows for biologics at Ferring Pharmaceuticals A/S, enabling highly efficient and reliable assessment of molecular properties.  

The session covers practical approaches for analyzing and interpreting biophysical data, with real-world examples to demonstrate how Genedata Screener streamlines the candidate profiling process and supports consistent, well-informed decision making in drug development.